Quinine‐ingestion has been associated with immune‐mediated recurrent pancytopenia, hemolysis, and renal failure. The structure of fluoroquinolone antibiotics is similar to the structure of quinine. Over a 3 month period, three patients at our institution developed hemolysis and renal failure following ingestion of the fluoroquinolone antibiotic temafloxacin. Two of the three patients required hemodialysis. Following withdrawal from the drug, the hemolysis resolved and the renal function eventually returned to normal in all three patients. One patient also had a transient mild thrombocytopenia. Sera from all three patients were tested for drug‐dependent antibodies to red blood cells, platelets, and neutrophils. Temafloxacin‐dependent red cell antibodies were detected in one patient, and temafloxacin‐dependent red cell and neutrophil antibodies were detected in a second patient. No temafloxacin‐dependent antibodies were detected in the third patient. Sera from all three patients were also tested for quinine and quinidine‐dependent antibodies to red cells, platelets, and neutrophils. Sera from the patient without temafloxacin‐dependent red cell antibodies reacted with red cells in the presence of quinine. These results suggest that, at least in some patients, the toxicities associated with temafloxacin are immune mediated. © 1994 Wiley‐Liss, Inc.
[1]
A. Campbell,et al.
Recurrent Pancytopenia, Coagulopathy, and Renal Failure Associated with Multiple Quinine-dependent Antibodies
,
1993,
Annals of Internal Medicine.
[2]
D. Stroncek,et al.
Characterization of multiple quinine-dependent antibodies in a patient with episodic hemolytic uremic syndrome and immune agranulocytosis
,
1992
.
[3]
A. Salama,et al.
Immune-mediated blood cell dyscrasias related to drugs.
,
1992,
Seminars in hematology.
[4]
G. Pankey.
Temafloxacin: an overview.
,
1991,
The American journal of medicine.
[5]
A. Pernet.
Temafloxacin: a safe antibiotic for the elderly, patients with comorbidities, and other special populations.
,
1991,
The American journal of medicine.
[6]
R. Aster,et al.
Quinine-induced immune thrombocytopenia associated with hemolytic uremic syndrome: a new clinical entity.
,
1991,
Blood.
[7]
Choo Pw,et al.
Reversible leukopenia related to ciprofloxacin therapy.
,
1990
.
[8]
A. Salama,et al.
The role of metabolite-specific antibodies in nomifensine-dependent immune hemolytic anemia.
,
1985,
The New England journal of medicine.